Promoter methylation of SFRPs gene family in cervical cancer

被引:54
作者
Chung, Ming-Tzeung [2 ,3 ]
Sytwu, Huey-Kang [2 ]
Yan, Ming-De [4 ]
Shih, Yu-Lueng [5 ,8 ]
Chang, Cheng-Chang [6 ]
Yu, Mu-Hsien [6 ]
Chu, Tang-Yuan [7 ]
Lai, Hung-Cheng [6 ,8 ]
Lin, Ya-Wen [1 ,8 ]
机构
[1] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei 114, Taiwan
[2] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan
[3] Army Forces Tao Yuan Gen Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan
[4] Natl Hlth Res Inst, Inst Canc Res, Zhunan, Miaoli County, Taiwan
[5] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Gastroenterol, Taipei 114, Taiwan
[6] Triserv Gen Hosp, Natl Def Med Ctr, Dept Obstet & Gynecol, Taipei 114, Taiwan
[7] Buddhist Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien, Taiwan
[8] Natl Def Med Ctr, Lab Epigenet, Taipei 114, Taiwan
关键词
Epigenetic inactivation; Cervical cancer; SFRP genes; FRIZZLED-RELATED PROTEIN; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; BETA-CATENIN; EPIGENETIC INACTIVATION; HYPERMETHYLATION; FREQUENT; DEMETHYLATION; ACTIVATION; EXPRESSION;
D O I
10.1016/j.ygyno.2008.10.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Oncogenic activation of the Wnt/beta-catenin signaling pathway is common in human cancers, including cervical cancer. The secreted frizzled-related proteins (SFRPs) function as negative regulators of Wnt signaling and play an important role in carcinogenesis. Frequent promoter hypermethylation of SFRPs has been identified in human cancers; however, the precise role of SFRPs in cervical cancer is not clear. Methods. The methylation status of SFRPs gene family was analyzed in two cervical cancer cell lines and a full spectrum of cervical neoplasia, including 45 low-grade squamous intraepithelial lesions (LSIL), 49 high-grade squamous intraepithelial lesions (HSIL), 109 squamous cell carcinomas (SCC), and 45 normal controls. Results. The SFRP1 promoter was hypermethylated in 33.9% of SCC, 8.2% of HSIL, 2.2% of LSIL, but not in normal tissues. The SFRP2 promoter was hypermethylated in 80.7% of SCC, 16.3% of HSIL, 15.6% LSIL and 4.4% normal tissues. The SFRP4 promoter was hype methylated in 67.9% of SCC, 36.7% of HSIL, 4.4% of LSIL, but not in normal tissues. The SFRP5 promoter was hypermethylated in 10.1% of SCC, 4.1% of HSIL, 13.3% of LSIL and 4.4% normal tissues. The frequency of SFRP1, SFRP2 and SFRP4 promoter methylation in tumors was significantly higher than in normal, LSIL, and HSIL samples (P<0.0001). SFRP5 methylation was significantly different in patients with or without lymph-node metastases (0% vs 15.2%, respectively, P<0.05). Conclusions. Our data suggest that promoter hypermethylation of SFRP1, SFRP2 and SFRP4 is associated with cervical carcinogenesis, which could be used for molecular screening of cervical neoplasias in future. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 35 条
[1]   DNA ploidy of cervical intraepithelial neoplasia (CIN) [J].
Atkin, NB ;
Baker, MC .
CANCER GENETICS AND CYTOGENETICS, 1997, 94 (02) :151-152
[2]   Wnt signaling: a common theme in animal development [J].
Cadigan, KM ;
Nusse, R .
GENES & DEVELOPMENT, 1997, 11 (24) :3286-3305
[3]   The Wnt antagonist sFRP1 in colorectal tumorigenesis [J].
Caldwell, GM ;
Jones, C ;
Gensberg, K ;
Jan, S ;
Hardy, RG ;
Byrd, P ;
Chughtai, S ;
Wallis, Y ;
Matthews, GM ;
Morton, DG .
CANCER RESEARCH, 2004, 64 (03) :883-888
[4]   A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites [J].
Chu, TY ;
Hwang, KS ;
Yu, MH ;
Lee, HS ;
Lai, HC ;
Liu, JY .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (02) :171-176
[5]  
Esteller M, 1999, CANCER RES, V59, P67
[6]   Detection of hypermethylated genes in women with and without cervical neoplasia [J].
Feng, QH ;
Balasubramanian, A ;
Hawes, SE ;
Toure, P ;
Sow, PS ;
Dem, A ;
Dembele, B ;
Critchlow, CW ;
Xi, LF ;
Lu, H ;
McIntosh, MW ;
Young, AM ;
Kiviat, NB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (04) :273-282
[7]   Caught up in a Wnt storm: Wnt signaling in cancer [J].
Giles, RH ;
van Es, JH ;
Clevers, H .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2003, 1653 (01) :1-24
[8]   Comprehensive molecular cytogenetic characterization of cervical cancer cell lines [J].
Harris, CP ;
Lu, XY ;
Narayan, G ;
Singh, B ;
Murty, VVVS ;
Rao, PH .
GENES CHROMOSOMES & CANCER, 2003, 36 (03) :233-241
[9]   Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma [J].
Herman, JG ;
Umar, A ;
Polyak, K ;
Graff, JR ;
Ahuja, N ;
Issa, JPJ ;
Markowitz, S ;
Willson, JKV ;
Hamilton, SR ;
Kinzler, KW ;
Kane, MF ;
Kolodner, RD ;
Vogelstein, B ;
Kunkel, TA ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6870-6875
[10]   SILENCING OF THE VHL TUMOR-SUPPRESSOR GENE BY DNA METHYLATION IN RENAL-CARCINOMA [J].
HERMAN, JG ;
LATIF, F ;
WENG, YK ;
LERMAN, MI ;
ZBAR, B ;
LIU, S ;
SAMID, D ;
DUAN, DSR ;
GNARRA, JR ;
LINEHAN, WM ;
BAYLIN, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :9700-9704